JT

James E. Talmadge

SL Smithkline Beecham Limited: 2 patents #570 of 1,624Top 40%
Genentech: 2 patents #1,171 of 2,392Top 50%
UN University Of Nebraska: 2 patents #192 of 808Top 25%
RX Rxkinetix: 1 patents #3 of 6Top 50%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
UR University Of Nebraska Board Of Regents: 1 patents #7 of 21Top 35%
CA Canji: 1 patents #29 of 50Top 60%
NI NIH: 1 patents #22 of 259Top 9%
📍 Frederick, MD: #80 of 816 inventorsTop 10%
🗺 Maryland: #3,562 of 35,612 inventorsTop 15%
Overall (All Time): #587,311 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
6649189 Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells Gary J. Rosenthal, Jeffrey B. Etter 2003-11-18
6551585 Use of tumor necrosis factor as an adjuvant H. Michael Shepard 2003-04-22
6475481 Purging of stem cell products 2002-11-05
5912232 Anti-inflammatory polypeptide antagonists of human I1-8 1999-06-15
5877276 Polypeptide agonists for human interleukin-8 1999-03-02
5776900 Hemoregulatory peptides Pradip Kumar Bhatnagar, William F. Huffman 1998-07-07
5627156 Polypeptide agonists for human interleukin-8 1997-05-06
5620957 Hemoregulatory peptides Pradip Kumar Bhatnagar, William F. Huffman 1997-04-15
4963354 Use of tumor necrosis factor (TNF) as an adjuvant H. Michael Shepard 1990-10-16